Courvalin Patrice
Unite des Agents Antibacteriens, Institut Pasteur, Paris, France.
Clin Infect Dis. 2006 Jan 1;42 Suppl 1:S25-34. doi: 10.1086/491711.
The first vancomycin-resistant clinical isolates of Enterococcus species were reported in Europe in 1988. Similar strains were later detected in hospitals on the East Coast of the United States. Since then, vancomycin-resistant enterococci have spread with unexpected rapidity and are now encountered in hospitals in most countries. This article reviews the mode of action and the mechanism of bacterial resistance to glycopeptides, as exemplified by the VanA type, which is mediated by transposon Tn1546 and is widely spread in enterococci. The diversity, regulation, evolution, and recent dissemination of methicillin-resistant Staphylococcus aureus are then discussed.
1988年欧洲报道了首例对万古霉素耐药的肠球菌临床分离株。随后在美国东海岸的医院中也检测到了类似菌株。从那时起,耐万古霉素肠球菌以意想不到的速度传播,现在在大多数国家的医院中都能发现。本文回顾了糖肽类抗生素的作用方式和细菌耐药机制,以由转座子Tn1546介导并在肠球菌中广泛传播的VanA型为例进行说明。随后讨论了耐甲氧西林金黄色葡萄球菌的多样性、调控、进化及近期传播情况。